Daily pill can double survival time for deadliest cancer, trial shows (theguardian.com)
A clinical trial of 500 patients found that a daily pill called daraxonrasib doubled survival time for patients with advanced pancreatic cancer, which is the world's deadliest cancer. The pill had fewer side effects than chemotherapy.